KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Non-Current Assets (2016 - 2025)

Globus Medical (GMED) has disclosed Non-Current Assets for 15 consecutive years, with $3.2 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Non-Current Assets rose 3.34% year-over-year to $3.2 billion, compared with a TTM value of $12.6 billion through Dec 2025, up 2.37%, and an annual FY2025 reading of $3.2 billion, up 3.34% over the prior year.
  • Non-Current Assets was $3.2 billion for Q4 2025 at Globus Medical, roughly flat from $3.2 billion in the prior quarter.
  • Across five years, Non-Current Assets topped out at $3.4 billion in Q3 2023 and bottomed at $923.5 million in Q1 2021.
  • Average Non-Current Assets over 5 years is $2.1 billion, with a median of $2.0 billion recorded in 2022.
  • The sharpest move saw Non-Current Assets soared 225.46% in 2023, then fell 11.9% in 2024.
  • Year by year, Non-Current Assets stood at $1.1 billion in 2021, then grew by 0.0% to $1.1 billion in 2022, then soared by 190.15% to $3.2 billion in 2023, then fell by 3.03% to $3.1 billion in 2024, then grew by 3.34% to $3.2 billion in 2025.
  • Business Quant data shows Non-Current Assets for GMED at $3.2 billion in Q4 2025, $3.2 billion in Q3 2025, and $3.2 billion in Q2 2025.